Avidity Partners Management LP 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 9:34 pm Sale |
2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Avidity Partners Management LP | 6,500,328 8.100% |
-324,122 (-4.75%) |
Filing |
| 2023-10-23 5:20 pm Purchase |
2023-10-18 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Avidity Partners Management LP | 6,824,450 9.700% |
6,824,450 (New Position) |
Filing |